Lisdexamfetamine 70 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DB25FFPQN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,497
Award facts
- Contract value 100% obligated
- $1,497.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lisdexamfetamine 70 mg capsules (90-count quantity) valued at $1,497.33 under a firm fixed-price contract with no set-aside designation. The order is set for ultimate completion by August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders for a wide spectrum of pharmaceutical products, including specialty medications, generic drugs, and medical supplies across multiple therapeutic domains. As a child contract under the larger SPE2DX prime indefinite delivery vehicle, this order represents part of AmerisourceBergen's ongoing support to military healthcare programs and other government healthcare systems globally, with the DLA planning to expand its Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions and contractors.
Quick answers
Who was awarded contract SPE2DB25FFPQN?
SPE2DB25FFPQN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FFPQN worth?
The government has obligated $1,497 on SPE2DB25FFPQN.
Is contract SPE2DB25FFPQN an order under another contract?
Yes. SPE2DB25FFPQN is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFPQN competed?
The extent of competition for SPE2DB25FFPQN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award